Abstract
Background
Medicinal cannabis use is topical in the media in Ireland. A recent Health Products Regulatory Authority review, however, has recommended against its use for patients with chronic pain. This is despite evidence for its effectiveness in this patient’s cohort and the inadequate pain management of these patients.
Aim
The aim of this study was to evaluate the attitudes of Irish patients with chronic pain towards medicinal cannabis.
Methods
After institutional ethics committee approval, a 12-item questionnaire (excluding demographics) was randomly assigned to patients attending a chronic pain clinic (University Hospital Limerick). The questionnaire was designed to incorporate patient’s attitudes on a variety of medicinal cannabis related topics.
Results
Ninety-six adult patients were surveyed. 88.54% agreed that cannabis should be legalised for chronic pain medicinal purposes. 80.21% believed it would have health benefits for them and 73.96% agreed it would be socially acceptable to use cannabis for this purpose. 33.33% perceived cannabis to be addictive while 68.75% would be willing to try it if prescribed by a medical professional.
Conclusions
The study highlights the attitudes of chronic pain patients in Ireland towards medicinal cannabis. It shows their desire to have medical cannabis legalised for chronic pain and that they view it as a reasonable pain management option.
Similar content being viewed by others
References
Hall W, Degenhardt L (2007) Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 20(4):393–397. https://doi.org/10.1097/YCO.0b013e32812144cc
Bostwick JM (2012) Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc 87(2):172–186. https://doi.org/10.1016/j.mayocp.2011.10.003
Rehm J, Fischer B (2015) Cannabis legalization with strict regulation, the overall superior policy option for public health. Clin Pharmacol Ther 97(6):541–544. https://doi.org/10.1002/cpt.93
Van den Brink W (2008) Forum: decriminalization of cannabis. Curr Opin Psychiatry 21(2):122–126. https://doi.org/10.1097/YCO.0b013e3282f57e04
Department of Health. Minister Harris announces ‘pivotal step’ on Medicinal Cannabis Access Programme [press release]. 2017. [Accessed: 15/12/2017] [Available from: http://health.gov.ie/blog/press-release/minister-harris-announces-pivotal-step-on-medicinal-cannabis-access-programme-prescribers-patients-and-pharmacists-to-draw-up-guidance-for-the-safe-use-of-cannabis-based-treatment/]
Health Products Regulatory Authority. Cannabis for medical use—a scientific review 2017 [Accessed: 15/12/2017] [Available from: https://www.hpra.ie/docs/default-source/publications-forms/newsletters/cannabis-for-medical-use---a-scientific-review.pdf?sfvrsn=7]
Lynch ME, Ware MA (2015) Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials. J NeuroImmune Pharmacol 10(2):293–301. https://doi.org/10.1007/s11481-015-9600-6
Breivik H, Collett B, Ventafridda V et al (2016) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10(4):287–333
Khelemsky Y, Goldberg AT, Hurd YL, Winkel G, Ninh A, Qian L, Oprescu A, Ciccone J, Katz DJ (2017) Perioperative patient beliefs regarding potential effectiveness of marijuana (cannabinoids) for treatment of pain: a prospective population survey. Reg Anesth Pain Med 42(5):652–659. https://doi.org/10.1097/AAP.0000000000000654
Otero MJ, Moreno-Gomez AM, Santos-Ramos B et al (2014) Developing a list of high-alert medications for patients with chronic diseases. Eur J Intern Med 25(10):900–908. https://doi.org/10.1016/j.ejim.2014.10.021
Williams J, van Ours JC, Grossman M (2016) Attitudes to legalizing cannabis use. Health Econ 25(9):1201–1216. https://doi.org/10.1002/hec.3340
Single E, Christie P, Ali R (2000) The impact of cannabis decriminalisation in Australia and the United States. J Public Health Policy 21(2):157–186
Crowley D, Collins C, Delargy I et al (2017) Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey. Harm Reduct J 14(1):4
Nussbaum AM, Boyer JA, Kondrad EC (2011) “But my doctor recommended pot”: medical marijuana and the patient-physician relationship. J Gen Intern Med 26(11):1364–1367. https://doi.org/10.1007/s11606-011-1840-4
Berkovic SF (2017) Cannabinoids for epilepsy—real data, at last. N Engl J Med 376(21):2075–2076. https://doi.org/10.1056/NEJMe1702205
Hall W, Degenhardt L (2009) Adverse health effects of non-medical cannabis use. Lancet 374(9698):1383–1391. https://doi.org/10.1016/S0140-6736(09)61037-0
Barry MJ, Edgman-Levitan S (2012) Shared decision making—pinnacle of patient-centered care. N Engl J Med 366(9):780–781. https://doi.org/10.1056/NEJMp1109283
Kondrad E, Reid A (2013) Colorado family physicians’ attitudes toward medical marijuana. J Am Board Fam Med 26(1):52–60. https://doi.org/10.3122/jabfm.2013.01.120089
Kleber HD, DuPont RL (2012) Physicians and medical marijuana. Am J Psychiatry 169(6):564–568. https://doi.org/10.1176/appi.ajp.2012.12030373
Grant I, Atkinson JH, Gouaux B, Wilsey B (2012) Medical marijuana: clearing away the smoke. Open Neurol J 6(1):18–25. https://doi.org/10.2174/1874205X01206010018
Kahan M, Srivastava A, Spithoff S et al (2014) Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations. Can Fam Physician 60(12):1083–1090
Serpell M, Ratcliffe S, Hovorka J et al (2014) A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. Eur J Pain 18(7):999–1012
Bostwick JM, Reisfield GM, DuPont RL (2013) Clinical decisions. Medicinal use of marijuana. N Engl J Med 368(9):866–868. https://doi.org/10.1056/NEJMclde1300970
Jones RT, Benowitz NL, Herning RI (1981) Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21 (8–9 Suppl):143s–152s
Barrett P, Bradley C (2016) Attitudes and perceived risk of cannabis use in Irish adolescents. Ir J Med Sci 185(3):643–647. https://doi.org/10.1007/s11845-015-1325-2
Broyd SJ, van Hell HH, Beale C, Yucel M, Solowij N (2016) Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biol Psychiatry 79(7):557–567. https://doi.org/10.1016/j.biopsych.2015.12.002
Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370(9584):319–328
Vicente J, Wiessing L (2007) European Monitoring Centre for Drugs and Drug Addiction annual report 2007: positive assessment of HIV in IDUs though hepatitis C still very high. Euro Surveill 12(11):E071122.6
Menghrajani P, Klaue K, Dubois-Arber F et al (2005) Swiss adolescents’ and adults’ perceptions of cannabis use: a qualitative study. Health Educ Res 20(4):476–484
Colorado Department of Public Health and Environment. The Colorado Medical Marijuana Registry 2017. [Accessed 15/12/2017] [Available from: https://www.colorado.gov/pacific/cdphe/2017-medical-marijuana-registry-statistics]
Russo EB, Guy GW, Robson PJ (2007) Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 4(8):1729–1743. https://doi.org/10.1002/cbdv.200790150
Whiting PF, Wolff RF, Deshpande S, di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J (2015) Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313(24):2456–2473. https://doi.org/10.1001/jama.2015.6358
Lynch ME (2011) The need for a Canadian pain strategy. Pain Res Manag n 16(2):77–80. https://doi.org/10.1155/2011/654651
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study protocol was approved by the research ethics committee of University Limerick Hospitals Group, Mid-West Region.
Conflict of interest
None.
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Rochford, C., Edgeworth, D., Hashim, M. et al. Attitudes of Irish patients with chronic pain towards medicinal cannabis. Ir J Med Sci 188, 267–272 (2019). https://doi.org/10.1007/s11845-018-1761-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-018-1761-x